Asset Details
Do you wish to reserve the book?
Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights
Do you wish to request the book?
Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights
2012
Overview
Diverticular disease imposes a significant burden on Western and industrialized societies. The traditional pathogenesis model posits that low dietary fiber predisposes to diverticulosis, and fecalith obstruction prompts acute diverticulitis that is managed with broad-spectrum antibiotics or surgery. However, a growing body of knowledge is shifting the paradigm of diverticular disease from an acute surgical illness to a chronic bowel disorder composed of recurrent abdominal symptoms and considerable psychosocial impact. New research implicates a role for low-grade inflammation, sensory-motor nerve damage, and dysbiosis in a clinical picture that mimics irritable bowel syndrome (IBS) and even inflammatory bowel disease (IBD). Far from being an isolated event, acute diverticulitis may be the catalyst for chronic symptoms including abdominal pain, cramping, bloating, diarrhea, constipation, and \"post-diverticulitis IBS.\" In addition, studies reveal lower health-related quality of life in patients with chronic diverticular disease vs. controls. Health-care providers should maintain a high index of suspicion for the multifaceted presentations of diverticular disease, and remain aware that it might contribute to long-term emotional distress beyond traditional diverticulitis attacks. These developments are prompting a shift in therapeutic approaches from widespread antimicrobials and supportive care to the use of probiotics, mesalamine, and gut-directed antibiotics. This review addresses the emerging literature regarding epidemiology, pathophysiology, and management of chronic, symptomatic diverticular disease, and provides current answers to common clinical questions.
Publisher
Nature Publishing Group,Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subject
/ Anti-Infective Agents - therapeutic use
/ Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
/ Biological and medical sciences
/ Dietary Fiber - administration & dosage
/ Diverticulitis - complications
/ Diverticulitis - drug therapy
/ Diverticulitis - epidemiology
/ Diverticulitis - physiopathology
/ Diverticulitis, Colonic - diagnosis
/ Diverticulitis, Colonic - epidemiology
/ Gastroenterology. Liver. Pancreas. Abdomen
/ Gastrointestinal Agents - therapeutic use
/ Humans
/ Inflammatory Bowel Diseases - diagnosis
/ Inflammatory Bowel Diseases - physiopathology
/ Irritable Bowel Syndrome - diagnosis
/ Irritable Bowel Syndrome - physiopathology
/ Mesalamine - therapeutic use
/ Probiotics - therapeutic use
